Inventor · disambiguated record
Mong Cho
Also filed as: CHO MONG
3 granted patents·9 pending applications·1 citations·filing 2004–2023
51Inventor score
Top patents by PatentIndex Score
12 records- 0171US11857585B2Oncolytic virus improved in safety and anticancer effectBIONOXX INC·Filed 2018·Granted Jan 2, 2024·1 cites·16 claims
- 0270US12220437B2Oncolytic virus improved in safety and anticancer effectBIONOXX INC·Filed 2023·Granted Feb 11, 2025·0 cites·13 claims
- 0350US2024181058A1Chimeric antigen receptor targeting oncolytic virus-derived protein, immunocyte expressing same, and uses of bothBIONOXX INC·Filed 2021·Application pending·0 cites
- 0449US2006134792A1Microarray comprising probes for drug-resistant hepatitis b virus detection, quality control and negative control, and method for detecting drug-resistant hepatitis b virus using the sameGENEIN CO LTD·Filed 2004·Application pending·0 cites
- 0545US2023096789A1Pharmaceutical composition for inhibiting inflammatory response comprising hydroxyureaBIONOXX INC·Filed 2021·Application pending·0 cites
- 0645US2022288143A1Pharmaceutical composition for treating cancer, comprising vaccinia virus and granulopoiesis inhibitor as active ingredientsBIONOXX INC·Filed 2020·Application pending·0 cites
- 0744US2022389085A1Tumor-targeting protein or fragment thereof, antibody binding thereto and use thereofBIONOXX INC·Filed 2020·Application pending·0 cites
- 0843US2022362316A1Pharmaceutical composition for treating cancer comprising anticancer virus, immune checkpoint inhibitor and hydroxyurea as active ingredientsBIONOXX INC·Filed 2019·Application pending·0 cites
- 0942US10517910B2Compositions and methods for viral embolizationSILLAJEN INC·Filed 2016·Granted Dec 31, 2019·0 cites·17 claims
- 1042US2022304960A1Pharmaceutical composition comprising vaccinia virus and hydroxyurea as active ingredient for treatment of cancerBIONOXX INC·Filed 2019·Application pending·0 cites
- 1141US2020405794A1Pharmaceutical composition for preventing or treating cancer comprising anticancer virus and hydroxyurea as effective componentsBIONOXX INC·Filed 2019·Application pending·0 cites
- 1240US2022202885A1Oncolytic virus with improved safety and anticancer effectsBIONOXX INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mong Cho files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →